Egyptian Healthtech Reme-D Raises $1.45M to Expand Molecular Diagnostics

Reme-D, an Egyptian healthtech company developing and manufacturing molecular diagnostic solutions, has closed a $1.45 million Pre-Series A funding round led by Anara Impact Capital, with participation from the Global Innovation Fund, Africa Health Ventures, and other investors. Founded with the aim of making advanced diagnostics more accessible across Africa and other underserved markets, Reme-D develops accurate, fast, affordable, and temperature-resilient diagnostic tests for diseases includi